Preclinical Efficacy of a Trivalent Human FcÎ³RI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection.

Kumar, Sudeep; Sunagar, Raju; Gosselin, Edmund J

Kumar, Sudeep; Sunagar, Raju; Gosselin, Edmund J.

Affiliation

Kumar S; Department of Immunology and Microbial Diseases, Albany Medical College, Albany, NY 12208, USA.
Sunagar R; Ella Foundation, Genome Valley, Hyderabad 500078, India.
Gosselin EJ; Department of Immunology and Microbial Diseases, Albany Medical College, Albany, NY 12208, USA.

Vaccines (Basel) ; 8(2)2020 Apr 23.

Article in En | MEDLINE | ID: mdl-32340134

Key words

Fc gamma receptor; antigen-presenting cell targeting; intranasal vaccine; mucosal adjuvant; mucosal vaccine; pneumococcal vaccine; subunit vaccine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Vaccines (Basel) Year: 2020 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Vaccines (Basel) Year: 2020 Document type: Article Affiliation country: United States